ResearcherFudan UniversityActive in the last 2 years

Yuxin Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1065-2809; OpenAlex author ID A5100782101. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Drug-loaded MITO@HA nanodrugs for evaluating the efficacy of targeted therapy for pancreatic cancer Last author DOI 10.21203/rs.3.rs-3972887/v1 ↗
Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells. Last author DOI 10.1166/jnn.2020.16949 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiudong Shi · 2 shared papers, 2020–2024 · strength 0.33
- Paper Drug-loaded MITO@HA nanodrugs for evaluating the efficacy of targeted therapy for pancreatic cancer DOI 10.21203/rs.3.rs-3972887/v1 ↗
- Paper Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells. DOI 10.1166/jnn.2020.16949 ↗
Fengjun Liu · 2 shared papers, 2020–2024 · strength 0.33
- Paper Drug-loaded MITO@HA nanodrugs for evaluating the efficacy of targeted therapy for pancreatic cancer DOI 10.21203/rs.3.rs-3972887/v1 ↗
- Paper Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells. DOI 10.1166/jnn.2020.16949 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.